Welcome to LookChem.com Sign In|Join Free

CAS

  • or

126712-05-8

Post Buying Request

126712-05-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

126712-05-8 Usage

Functional Groups

Bromine (Br), Methoxy (-OCH3)

Physical State

Colorless liquid

Aroma

Strong, sweet

Application

Organic synthesis, intermediate in pharmaceuticals, pesticides, and fragrances

Hazards

Potential irritant to skin, eyes, and respiratory system

Health Risks

Exposure to high levels may cause adverse health effects

Safety Precautions

Handle with care, use appropriate protective equipment (gloves, goggles, etc.)

Check Digit Verification of cas no

The CAS Registry Mumber 126712-05-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,7,1 and 2 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 126712-05:
(8*1)+(7*2)+(6*6)+(5*7)+(4*1)+(3*2)+(2*0)+(1*5)=108
108 % 10 = 8
So 126712-05-8 is a valid CAS Registry Number.

126712-05-8Relevant articles and documents

Total synthesis of (S)-equol

Heemstra, Jennifer M.,Kerrigan, Sean A.,Doerge, Daniel R.,Helferich, William G.,Boulanger, William A.

, p. 5441 - 5443 (2006)

The first enantioselective total synthesis of (S)-equol is reported. The described route relies on an Evans alkylation to form the stereocenter and an intramolecular Buchwald etherification to generate the chroman ring. Key features of this method include its brevity, its scalability, and the low cost of starting materials.

SPIRO AROMATIC RING COMPOUND AND APPLICATION THEREOF

-

Paragraph 0227, (2020/10/20)

Provided is a compound of formula I or a pharmaceutically acceptable salt, enantiomer, diastereomer, tautomer, solvate, isotopic substituent, polymorph, prodrug, or metabolite thereof. Also provided is a method for preparing the compound of formula I. The compound of formula I has higher inhibitory activity against SHP2, and thus can be used to prevent or treat a disease related to SHP2.

Divergent Enantioselective Synthesis of (Nor)illudalane Sesquiterpenes via Pd0-Catalyzed Asymmetric C(sp3)-H Activation

Melot, Romain,Craveiro, Marcus V.,Bürgi, Thomas,Baudoin, Olivier

, p. 812 - 815 (2019/01/21)

A divergent enantioselective synthesis of (nor)illudalane sesquiterpenes was designed by using a Pd0-catalyzed asymmetric C(sp3)-H arylation as a key step to control the isolated, highly symmetric quaternary stereocenter of the targe

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 126712-05-8